Mayne Pharma Group Ltd has released a press release.
MYX signs license agreement for contraceptive in Australia
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Mayne Pharma submits NDA for E4/DRSP to the FDA
- 2020 Half Year Investor Presentation
- 2020 Half Year Media Release
- 2019 AGM CEOs Speech
- E4/DRSP contraceptive presented at EU gynecology conference
Later from Mayne Pharma
- S&P DJI Announces June 2020 Quarterly Rebalance
- MYX announces FDA filing acceptance of E4/DRSP in the US
- Mayne Pharma announces strategic partnership with Novast
- 2020 Full Year Media Release
- 2020 Full Year Investor Presentation
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma